Human African Trypanosomiasis

被引：28

作者：

Brun, Reto ^{[1
]}

Blum, Johannes ^{[2
]}

机构：

[1] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland

[2] Swiss Trop & Publ Hlth Inst, Dept Med Serv & Diagnost, Outpatient Clin, CH-4002 Basel, Switzerland

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2012年 / 26卷 / 02期

关键词：

Human African trypanosomiasis; Sleeping sickness; Trypanosoma brucei gambiense; Trypanosoma brucei rhodesiense; Epidemiology; Diagnosis; Treatment; CATT/TRYPANOSOMA-BRUCEI-GAMBIENSE; SLEEPING SICKNESS; DIAGNOSIS; SURVEILLANCE; EFLORNITHINE; MELARSOPROL; RHODESIENSE; TRIAL; STAGE; MRI;

D O I：

10.1016/j.idc.2012.03.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Human African trypanosomiasis (sleeping sickness) is caused by the uni-cellular parasite Trypanosoma brucei and transmitted by tsetse flies. It occurs exclusively in sub-Saharan Africa, usually in rural areas affected by civil conflicts and neglected health systems. Reported cases are fewer than 10,000/year, which classifies it as one of the most neglected tropical diseases. Because sleeping sickness is fatal if not treated, it has to be included in the differential diagnosis of every febrile traveler returning from a game park in East Africa. Elimination of the disease is considered feasible provided better tools for diagnosis and treatment can be made available.

引用

页码：261 / +

页数：14

共 50 条

[31] Current chemotherapy of human African trypanosomiasis
Docampo, R
Moreno, SNJ
[J]. PARASITOLOGY RESEARCH, 2003, 90 (Suppl 1) : S10 - S13
[32] Drug resistance in human African trypanosomiasis
Barrett, Michael P.
Vincent, Isabel M.
Burchmore, Richard J. S.
Kazibwe, Anne J. N.
Matovu, Enock
[J]. FUTURE MICROBIOLOGY, 2011, 6 (09) : 1037 - 1047
[33] AFRICAN HUMAN TRYPANOSOMIASIS - IMMUNOENZYMOLOGICAL DIAGNOSIS
CAILLIEZ, M
POUPIN, F
SAVEL, J
[J]. NOUVELLE PRESSE MEDICALE, 1979, 8 (07): : 522 - 523
[34] Eflornithine for the treatment of human African trypanosomiasis
Burri, C
Brun, R
[J]. PARASITOLOGY RESEARCH, 2003, 90 (Suppl 1) : S49 - S52
[35] Oral fexinidazole for human African trypanosomiasis
Chappuis, Francois
[J]. LANCET, 2018, 391 (10116): : 100 - 102
[36] IMMUNOLOGICAL DIAGNOSIS OF HUMAN AFRICAN TRYPANOSOMIASIS
SAVEL, J
COULAUD, JP
[J]. MEDECINE ET MALADIES INFECTIEUSES, 1979, 9 (05): : 293 - 295
[37] Human African trypanosomiasis–neurological aspects
P. G. E. Kennedy
[J]. Journal of Neurology, 2006, 253 : 411 - 416
[38] The epidemiology and control of human African trypanosomiasis
Pépin, J
Méda, HA
[J]. ADVANCES IN PARASITOLOGY, VOL 49, 2001, 49 : 71 - 132
[39] The human African trypanosomiasis (HAT) platform
Mbo, F.
Valverde, O.
[J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 : 239 - 239
[40] Recent developments in human African trypanosomiasis
Welburn, SC
Odiit, M
[J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (05) : 477 - 484

← 1 2 3 4 5 →